Actualités

On August 11, medtech leader Abbott Laboratories (NYSE:ABT) and tech behemoth Alphabet Inc. (NASDAQ:GOOG) announced a multi-year partnership to unite continuous glucose monitoring with consumer AI. The collaboration embeds data from Abbott’s non-prescription Lingo biowearable directly into the Google Health app, combining real-time metabolic insights with Google’s AI Health Coach to deliver personalized habit recommendations […]

MMED expands its European diabetes tech reach with Abbott sensor integration, boosting user flexibility and its connected care ecosystem.

Overseas markets are central to MiniMed’s business, accounting for 70% of reported net sales in the company’s 2026 financial year.

Similac, Abbott Laboratories' (NYSE:ABT) infant nutrition brand, has launched its "Love Without Measure" initiative. The campaign focuses on easing social media pressures on young and Gen Z parents and promoting a more supportive online community. Similac is partnering with motherhood experts and social media influencers to highlight mental health, inclusivity, and judgment free parenting. For investors following Abbott Laboratories, the move highlights how the company is engaging with...

The latest generation of the coronary intravascular lithotripsy device is designed to be more flexible to help physicians navigate tight arteries to break up calcified deposits and restore blood flow.